Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Clinical overlap between peripheral arterial disease (PAD), coronary artery disease (coronary), and cerebrovascular disease (cerebral) in the Trans-Atlantic Inter-Society Consensus (TASC) working group with nearly 2,000 patients (left) and in the Clopidogrel versus Aspirin in Patients at Risk of Ischemia Events (CAPRIE) trial with nearly 20,000 patients (right). Compiled from data in the TASC Working Group (10) and the CAPRIE Steering Committee (12).
|
